HIVST@orasure.com Phone: 011-44-7771-844456

About OraQuick^® HIV Self-Test (HIVST)

The OraQuick^® HIV Self-Test (HIVST) is a rapid, point-of-care test that allows an individual to detect antibodies to both HIV-1 and HIV-2 with a simple oral swab and provides a result in as little as 20 minutes in the privacy of an individual’s home, at outreach testing settings, in the pharmacy or at community based screening events.

Based on the same OraQuick^® platform that is used for the FDA-approved OraQuick In-Home HIV Test and the WHO Prequalified OraQuick Rapid HIV-1/2 Antibody Test used by health care professionals worldwide, the platform has been used to test millions.

What is the Bill and Melinda Gates Foundation agreement with OraSure Technologies?

The agreement with the Bill & Melinda Gates Foundation will enable OraSure to offer its OraQuick^® HIV Self-Test at an affordable price in 50 developing countries with funding from the Gates Foundation.  The funding will consist of support payments tied to the volume of product sold by OraSure and reimbursement of certain related costs.

Through this agreement, funding from the Gates Foundation will enable non-governmental organizations in eligible countries that receive funding from government or public sector agencies and donors such as the Children’s Investment Fund Foundation (UK), the Global Fund, PEPFAR and UNITAID to access HIV self-testing at reduced pricing.

What Countries are eligible to participate in the program?

How to use the OraQuick HIV Self-Test

Download Instructions - English

Interested in more information on pricing or implementation?

HIVST@orasure.com - 011 44 7771 844456

The information provided on this website is intended only for the residents of the U.S. The products discussed herein may have different labeling in different countries and may not be for sale in all other countries.